Last reviewed · How we verify
GIP Bolus
At a glance
| Generic name | GIP Bolus |
|---|---|
| Sponsor | Diabeteszentrum Bad Lauterberg im Harz |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies (PHASE4)
- The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease
- The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP (PHASE1)
- Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GIP Bolus CI brief — competitive landscape report
- GIP Bolus updates RSS · CI watch RSS
- Diabeteszentrum Bad Lauterberg im Harz portfolio CI